Media & Investors

Investor FAQs

Where is Calithera headquartered?

Calithera Biosciences is headquartered at 343 Oyster Point Blvd., Suite 200 South San Francisco, CA 94080.

Where is the company incorporated?

Calithera is incorporated in the state of Delaware.

How is Calithera’s stock traded?

Calithera trades on the NASDAQ Global Select Market under the symbol CALA and its CUSIP number for the common stock is 13089P101.

How can I buy or sell Calithera common stock?

You may purchase shares of our common stock through any brokerage, bank or other financial institution that is authorized to trade in shares of publicly held securities.

When did Calithera go public?

Calithera’s initial public offering (IPO) was on October 1, 2014.

When does the company’s fiscal year end?

The fiscal year end is December 31.

Who is Calithera’s transfer agent?

American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, New York 11219

Whom should I notify if my address changes?

Communication regarding change of address can be directed to our transfer agent, American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, New York 11219

Who are Calithera’s independent auditors?

Ernst & Young 275 Shoreline Drive, #600 Redwood City, CA 94065

Who is Calithera’s legal counsel?

Cooley, LLP 3175 Hanover Street Palo Alto, CA 94304-1130

Whom can I contact if I have an investor relations question?

You can contact Calithera’s investor relations team at 650-870-1071.